Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.540
-0.005 (-0.94%)
At close: Jun 26, 2026, 4:00 PM EDT
0.550
+0.010 (1.85%)
After-hours: Jun 26, 2026, 6:18 PM EDT
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2025. The number of employees did not change compared to the previous year.
Employees
23
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$243,974
Profits / Employee
-$2,008,743
Market Cap
14.82M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| Lunai Bioworks | 29 |
| Passage Bio | 24 |
| Werewolf Therapeutics | 14 |
| BioVie | 13 |
| Tvardi Therapeutics | 12 |
| Cocrystal Pharma | 10 |
| Exicure | 2 |
CTXR News
- 26 days ago - Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO - TheFly
- 26 days ago - Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies - PRNewsWire
- 4 weeks ago - Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncology Annual Meeting - PRNewsWire
- 5 weeks ago - Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders - TheFly
- 5 weeks ago - Citius Pharmaceuticals Registration statement: Registration filing - Filings
- 5 weeks ago - Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright - TheFly
- 6 weeks ago - Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - PRNewsWire